Search
Viral Vectors
DNA
Antibiotic-free Maintenance System (ORT®)
Microbiota
Technical Protein
Fill Finish
Search
About
Events
Our Commitment to You
Our Mission & Values
Code of Conduct
Project Management
Quality Assurance
Our History
Sustainability
Careers
News
Contact Us
Select Language
Español
Deutsch
한국의
Français
Svenska
中国的
日本の
Menu
News
Discover the latest news stories, blog posts and publications from Cobra's expert team
Home
/
News
Toggle filters
Posts by Tag
August 2020
(5)
November 2017
(4)
April 2020
(4)
May 2013
(3)
October 2013
(3)
April 2017
(3)
July 2017
(3)
January 2018
(3)
November 2019
(3)
March 2020
(3)
February 2021
(3)
June 2011
(2)
October 2011
(2)
February 2012
(2)
June 2012
(2)
October 2012
(2)
March 2013
(2)
February 2014
(2)
March 2014
(2)
June 2014
(2)
February 2015
(2)
September 2015
(2)
June 2016
(2)
November 2016
(2)
January 2017
(2)
December 2017
(2)
February 2018
(2)
March 2018
(2)
September 2018
(2)
October 2019
(2)
October 2020
(2)
December 2020
(2)
January 2021
(2)
April 2021
(2)
January 2011
(1)
February 2011
(1)
July 2011
(1)
September 2012
(1)
November 2012
(1)
January 2013
(1)
June 2013
(1)
August 2013
(1)
December 2013
(1)
January 2014
(1)
April 2014
(1)
May 2014
(1)
September 2014
(1)
December 2014
(1)
March 2015
(1)
April 2015
(1)
May 2015
(1)
July 2015
(1)
August 2015
(1)
November 2015
(1)
February 2016
(1)
March 2016
(1)
May 2016
(1)
July 2016
(1)
October 2016
(1)
March 2017
(1)
May 2017
(1)
September 2017
(1)
October 2017
(1)
April 2018
(1)
June 2018
(1)
October 2018
(1)
November 2018
(1)
January 2019
(1)
June 2019
(1)
September 2019
(1)
January 2020
(1)
June 2020
(1)
September 2020
(1)
March 2021
(1)
June 2021
(1)
See all
or
Posts by Tag
Gene Therapy
(24)
General
(22)
DNA
(17)
Viral Vectors
(16)
blog
(16)
COVID-19
(12)
vaccine
(12)
Coronavirus
(10)
Awards
(9)
Collaboration
(8)
Manufacturing
(8)
cell therapy
(8)
expansion
(8)
business
(7)
award
(6)
international trade
(6)
plasmid dna
(6)
AAV
(5)
CombiGene
(5)
gene
(5)
immunotherapy
(5)
investment
(5)
therapy
(5)
Cobra Biologics
(4)
Cognate BioServices
(4)
Innovate UK
(4)
News
(4)
Proteins
(4)
STEM
(4)
University
(4)
acquisition
(4)
#21Cmed
(3)
Advanced Therapy Medicinal Product
(3)
Alligator
(3)
Bionow
(3)
CG01
(3)
CPI
(3)
Featured
(3)
Innovate
(3)
adeno-associated virus
(3)
clinical trials
(3)
epilepsy
(3)
export
(3)
grant
(3)
jobs
(3)
maxXpress
(3)
oxford
(3)
viral
(3)
A-level choices
(2)
ATMP
(2)
Advanced Therapies Manufacturing Taskforce
(2)
Careers in Science
(2)
Centre for Process Innovation
(2)
Charles River
(2)
Expertise
(2)
Finalists
(2)
GCSE options
(2)
GE Healthcare
(2)
GMP
(2)
Immune-oncology
(2)
Immuno-Oncology
(2)
Industrial Strategy
(2)
Karolinska
(2)
Manchester
(2)
OPENCORONA
(2)
Pharma
(2)
Quality
(2)
Queen's Award
(2)
Staffordshire
(2)
Thought Leader
(2)
Trade
(2)
UK medicine
(2)
Vaccines
(2)
antibody
(2)
branding
(2)
cell line development
(2)
clinical
(2)
competition
(2)
development
(2)
education
(2)
expression
(2)
interview
(2)
medicine
(2)
regenerative
(2)
science
(2)
vector
(2)
vectors
(2)
viral vector
(2)
vlog
(2)
ADC-1013
(1)
ADCs
(1)
ATAC
(1)
AstraZeneca
(1)
BioSpace
(1)
Bioscience
(1)
CAR-T
(1)
CDMO
(1)
CMO
(1)
CSO
(1)
Cancer
(1)
Capabilities
(1)
Capsules
(1)
Cell and Gene Therapy Catapult
(1)
Chambers
(1)
Cobra
(1)
Commerce
(1)
Compatibility
(1)
Director
(1)
Engineered
(1)
Future
(1)
Highlights
(1)
Innovation
(1)
Internal
(1)
Leukoencephalopathy
(1)
MHRA
(1)
Manufacturer
(1)
Multifocal
(1)
NEUWAY
(1)
Pall Corporation
(1)
ProFuse
(1)
Progressive
(1)
Puridify
(1)
Reliability
(1)
Sartorius
(1)
Sheffield
(1)
Staffs
(1)
Stedim
(1)
SwedenBIO
(1)
Symbiosis
(1)
Technologies
(1)
Tokyo
(1)
Tony Hitchcock
(1)
Touchlight
(1)
UCOE
(1)
UKTI
(1)
Viruses
(1)
Webinar
(1)
YEOTY
(1)
adenovirus
(1)
advanced
(1)
alevel choices
(1)
antibodies
(1)
apprenticeships
(1)
baculovirus
(1)
bioreactor
(1)
careers
(1)
cell
(1)
cmo leadership award
(1)
commercial supply
(1)
compliance
(1)
costs
(1)
covid19
(1)
degree choices
(1)
department
(1)
disease
(1)
disposables
(1)
event
(1)
goals
(1)
growth
(1)
jenner institute
(1)
leadership
(1)
life
(1)
line
(1)
microbial
(1)
mobile
(1)
neurodegenerative
(1)
new website
(1)
of
(1)
operations
(1)
orphan
(1)
partnership
(1)
partnerships
(1)
peer reviewed
(1)
process
(1)
processes
(1)
promising technologist
(1)
protein
(1)
rare
(1)
rare disease day
(1)
regulatory
(1)
relationship
(1)
responsive
(1)
risk
(1)
scancell
(1)
scientist
(1)
service
(1)
social media
(1)
solid
(1)
studies
(1)
study
(1)
supply
(1)
survey
(1)
technology
(1)
therapeutics
(1)
timelines
(1)
toxicity
(1)
trial
(1)
trials
(1)
tumours
(1)
visitor experience
(1)
web design
(1)
website
(1)
See all
Links & Downloads: Cobra Articles
Viral Vectors
,
DNA
,
Vaccines
,
Thought Leader
A selection of articles authored by, or including interviews with, the Cobra team
A selection of links and downloadable magazine articles
Albumedix extends research collaboration with Cobra Biologics
Process optimization and stability enhancement in scale-up manufacturing of AAV and lentiviral vectors through Albumedix' proprietary recombinant human albumin-based product
INTERVIEW: Matti Sällberg discusses OPENCORONA on SVT
vaccine
,
Coronavirus
,
COVID-19
,
OPENCORONA
,
Karolinska
Cobra is proud to be part of the OPENCORONA consortium, supporting global efforts to tackle the pandemic
Cobra is proud to be part of a consortium, led by the Jenner Institute, Oxford University to rapidly develop a COVID-19 vaccine
Charles River Laboratories Completes the Acquisition of Cognate BioServices
Featured
,
Gene Therapy
,
cell therapy
,
acquisition
,
Charles River
The acquisition establishes Charles River as a premier scientific partner for cell and gene therapy development, testing, and manufacturing, providing clients with an integrated solution from basic research and discovery through CGMP production.
Charles River to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development
Gene Therapy
,
cell therapy
,
acquisition
,
Charles River
Significantly Expands Charles River’s Scientific Capabilities in the High-Growth Cell and Gene Therapy Sector & Combines Cognate’s Comprehensive Cell and Gene Therapy CDMO Capabilities to Establish an Integrated Solution from Discovery through CGMP Manufacturing
INTERVIEW: Thomas Moore, Sky News, reports on a new COVID-19 vaccine in development
Featured
,
vaccine
,
Coronavirus
,
COVID-19
Thomas Moore is joined by Prof. Lindy Durrant, CEO/CSO Scancell, and Alex Brownfield, Cobra Business Development Director
Biologics manufacturing capacity and the challenges of scaling up vaccine production to fast track one million doses by September
Cobra Biologics Team Celebrates Double Award Win
COVID-19
,
Awards
,
Bionow
,
ATAC
,
apprenticeships
Recognising the company's contribution to the fight against COVID-19, and in providing an alternative route to the workplace through advanced therapies apprenticeships
Cobra Biologics Shortlisted for Two Bionow Awards 2021
Awards
,
Bionow
The annual awards recognise the outstanding success and achievements of those who have worked tirelessly throughout the year and spotlight the incredible progress that has been made during this challenging period.
Cognate BioServices, and its gene therapy division Cobra Biologics Announce Major Expansion of Manufacturing Facilities in US and Europe
Gene Therapy
,
ATMP
,
expansion
,
cell therapy
,
Cognate BioServices
This includes a four-fold increase in HQ (High Quality) DNA manufacturing capacity alongside new clinical and commercial GMP DNA facilities at its European facilities
Links & Downloads: Peer Reviewed Publications
Viral Vectors
,
peer reviewed
,
plasmid dna
,
Vaccines
,
Thought Leader
A selection of downloadable journal articles and book chapters from the team at Cobra
Cobra Biologics Awarded Breaking the Mould Company of the Year 2020
Awards
Cobra Biologics was presented with the Company of the Year award for demonstrating inspirational, motivational and meaningful growth over the past 12 months.
1
2
3
4
5
